| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 100.654 | 106.968 | 138.505 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 100.659 | 106.970 | 138.512 |
| Total Expenses - EUR | - | - | - | - | - | - | 946 | 19.738 | 21.631 | 73.205 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -946 | 80.921 | 85.340 | 65.307 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -946 | 79.948 | 84.293 | 61.840 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Diamed Neurologie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 78 | 8.190 | 7.189 | 5.589 |
| Current Assets | - | - | - | - | - | - | 96 | 71.512 | 73.556 | 75.222 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 889 | 518 |
| Receivables | - | - | - | - | - | - | 0 | 48.573 | 33.301 | 34.961 |
| Cash | - | - | - | - | - | - | 96 | 22.938 | 39.366 | 39.743 |
| Shareholders Funds | - | - | - | - | - | - | -905 | 79.039 | 79.600 | 78.348 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.160 | 850 | 1.184 | 2.567 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diamed Neurologie S.r.l.